Juan Carlos Bucobo, MD
Dr Juan Carlos Bucobo is the Vice President of Gastroenterology Services for Northwell Health and the President and Executive Director of the Northwell GI Institute and IPA. Dr Bucobo is committed to developing programs of excellence in gastroenterology and ensuring the delivery of top-notch, quality care to the local communities Northwell Health serves. He is an advanced endoscopist with a special interest in the diagnosis and treatment of complicated pancreaticobiliary disorders and in the resection of gastrointestinal lesions by minimally invasive, endoscopic approaches. He is committed to delivering state-of-the-art therapeutic advanced endoscopy care with compassion and sensitivity to the needs of patients and their families. Dr Bucobo is the President of the New York Society for Gastroenterology and Endoscopy (NYSGE), he is a course director for the ASGE Post Graduate Course at ACG in Vancouver and is an active member on several national committees including the ASGE Colorectal Cancer Screening Project Advisory Council. He lectures nationally and internationally on several topics related to advanced endoscopy and on reducing healthcare disparities in gastroenterology and is an author of several peer-reviewed articles, abstracts, and book chapters. Prior to joining Northwell Health, Dr Bucobo was the Assistant Dean for Clinical Outreach at Stony Brook School of Medicine, President of Stony Brook Community Medical and the Chief of Endoscopy for Stony Brook Medicine. Dr Bucobo completed his advanced endoscopy training at Cedars-Sinai Medical Center, his gastroenterology fellowship at Stony Brook Medicine where he also completed his internal medicine residency following his internship at Montefiore Medical Center/Albert Einstein School of Medicine.
Reem Sharaiha, MD
Dr. Reem Sharaiha is an Associate Professor of Medicine at the Weill Medical College of Cornell University. She is the director of Interventional and Therapeutic endoscopy as well as the director of bariatric and metabolic endoscopy. She is a pioneer in the field and an expert advanced endoscopist in pancreaticobiliary disease and in endoscopic (non surgical) treatment for weight loss and the improvement of weight-related health conditions. She is board certified in gastroenterology, internal medicine, and obesity (in both the United States and UK) and is also an advanced fellowship trained interventional gastroenterologist. She received her medical degree from the University of London (St George’s Hospital). She completed her Internal Medicine residency at New York Presbyterian Hospital-Weill Cornell Campus and her fellowship at New York Presbyterian Hospital-Columbia Campus, where she received a masters in patient oriented research (biostatistics). She completed her Fellowship training in Gastroenterology at Columbia University Medical Center, and her Advanced Endoscopy Fellowship at Johns Hopkins University Hospital. Her research is primarily focused on interventional endoscopy. A major focus of her research is on endoscopic treatment options for obesity, as well as ablation therapies for malignancy and treatment of pancreatic fluid collections. Dr. Sharaiha has published more than 200 peer reviewed articles, reviews, and book chapters in the field. Her work has been highly cited. She is also grant funded and participates in many FDA and device initiated trials. Her objectives are to develop and understand the new endoscopic techniques for reducing the obesity epidemic, and understand the safety and efficacy of such techniques and their impact on comorbidities. Dr. Sharaiha has been invited to give many national and international keynote lectures. She serves as member to multiple national and international societies to help develop current practice guidelines.
Tamas Gonda, MD
Dr. Tamas Gonda is the Chief of Endoscopy at NYU-Tisch Hospital and the Director of the Pancreas Disease Program. His clinical practice is focused on therapeutic endoscopy with a primary interest in treatment and prevention of pancreatobiliary diseases and a specific focus on therapeutic EUS for the diagnosis, palliation and treatment of pancreatic diseases . He has lead investigator-initiated and collaborative clinical trials in the treatment of pancreatic cancer, pancreatitis, prevention and treatment of pancreatic and other gastrointestinal precursors and novel endoscopic technologies or therapies. His translational research lab is focused on epigenetics and epigenetic therapies in the early detection and treatment of pancreatic cancer.
David L. Carr-Locke, MD
David Carr-Locke grew up in Melksham, Wiltshire, England, was educated at Chippenham Grammar School and received his medical degree from Cambridge University and the Middlesex Hospital Medical School, London, UK in 1972. He completed his internship at Kettering General Hospital, UK, his residency and gastroenterology fellowship at the University of Leicester, UK, and a research fellowship at the New England Baptist Hospital, Boston, USA. He was a Lecturer in the Department of Medicine at the new Leicester Medical School and one of the few full-time Consultants in Gastroenterology in the UK at that time at Leicester Royal Infirmary until 1989 when he was appointed Director of Endoscopy at Brigham and Women’s Hospital, Harvard Medical School, Boston. After 21 years’ service in Boston, he moved to New York in 2010 to become Chief of the Division of Digestive Diseases, at Beth Israel Medical Center and Professor of Medicine at Albert Einstein College of Medicine later Professor, Icahn School of Medicine after the merger with Mount Sinai in 2013. In January 2017 he became the Clinical Director of The Center for Advanced Digestive Care at Weill Cornell Medical College and New York Presbyterian Hospital. He is a Past-President of the International HepatoPancreatoBiliary Association (1994/6), American Society for Gastrointestinal Endoscopy (ASGE, 2002/3), International Society for Endomicroscopy (2016/20) and New York Society for Gastrointestinal Endoscopy (2021/22). He was recipient of the ASGE’s highest recognition, the Rudolf Schindler Award, in 2007.
He has an international reputation as an endoscopist and educator in therapeutic endoscopy (he has delivered more than 1,000 lectures during his career) and has pioneered many of the techniques used today for treating patients with gastrointestinal and pancreaticobiliary disease. He will be 75 in 2023 and continues to maintain a busy clinical schedule. He has trained over 160 gastroenterology and advanced endoscopy fellows. He pursues an active clinical research interest and has published more than 300 articles, book chapters, books and videos on many aspects of therapeutic endoscopy. He recently published groundbreaking findings on the new human interstitium which may change the way we think about many diseases and the spread of cancer and, during the COVID-19 pandemic, published on many areas affecting gastroenterology practice.
What I Do at MSK
- Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
I chose gastroenterology because it is a wonderful combination of clinical patient care, endoscopic procedures, and research. I love caring for people with a wide variety of diseases and enjoy being part of the entire spectrum of cancer-related care, from screening to end-of-life care.
I have expertise in performing a variety of gastrointestinal endoscopic procedures, including colonoscopy and upper gastrointestinal endoscopy. I am also skilled at performing advanced endoscopic techniques, such as complex polypectomies and direct percutaneous endoscopic jejunostomies (placing a feeding tube directly in the small intestine). Cancer can sometimes create obstacles to daily activities, such as eating, and many of the procedures I perform help patients feel better by taking care of these quality of life needs for them.
In recent years, we have been able to reduce colon cancer rates because more people are getting screened appropriately. Though this is important progress, we have begun to see an increase in the number of younger people being diagnosed with this disease. My research aims to find out why this number is rising. I am also investigating how best to care for younger people with colon cancer to ensure we are addressing their specific long-term concerns and goals, such as fertility.
Brian Bosworth, MD
Dr. Bosworth serves as the Chief Medical Officer of the NYU Langone Health System. He obtained his undergraduate degree from Princeton University where he graduated magna cum laude in Classics; his medical doctorate from Columbia University College of Physicians and Surgeons and subsequently completed his internship, residency and chief residency in Internal Medicine at New York Presbyterian Hospital: Columbia-Presbyterian. He pursued his fellowship in Gastroenterology at Weill Cornell and remained on faculty specializing in Inflammatory Bowel Disease and served as the Director of the GI Fellowship Program and an Associate Program Director of the Internal Medicine Residency Program.
In 2016, Dr. Bosworth joined NYU Langone Health as Chief of Medicine for the Main Manhattan Campus and was named CMO in 2021. Dr. Bosworth has a wealth of leadership experiences and is dedicated to excellence in education, research, and high quality, safe and equitable patient centered care.
Amrita Sethi, MD
Amrita Sethi is a Professor of Medicine at Columbia University Medical Center in New York and is the Director of Interventional Endoscopy and the Advanced Endoscopy Fellowship Program Director. She completed her GI fellowship at Medical College of Virginia, and then her Advanced Endoscopy Fellowship at University of Colorado. She has been an attending advanced endoscopist at Columbia since 2008. Her practice interests include ERCP and cholangioscopy, therapeutic EUS, ESD, POEM and other areas of third space endoscopy and endoscopic innovation.
In addition to her work with the national GI societies, such as the ASGE, AGA and ACG, she is the founder and president of Women in Endoscopy (WIE), a global organization started to foster mentorship and promote leadership for women in interventional endoscopy. She is the the Chair of the AGA’s Center for GI Innovation and Technology, a past President of the NYSGE. And in 2020 she received the ASGE Master Endoscopist Award, which recognizes her accomplishments and contributions to the endoscopic community.
David Greenwald, MD
Dr. David Greenwald is currently the Director of Clinical Gastroenterology and Endoscopy at Mount Sinai Hospital in New York City and Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Previously, he was Fellowship Program Director in Gastroenterology at Montefiore Medical Center/Albert Einstein College of Medicine for nearly two decades and was an Associate Division Director of the Division of Gastroenterology at Montefiore Medical Center in the Bronx, New York. He is a past president of the New York Society for Gastrointestinal Endoscopy, and currently serves as that organization’s Education Director. He is a Past President and a member of the Board of Trustees for the American College of Gastroenterology, and previously was the Chairman of the Board of Governors. He was recognized by ASGE with a Master Endoscopist Award in 2006. He was a Board Member and Chair of the Research Committee of GIQuIC, the GI Quality Improvement Consortium and has been a member of the Steering Committee of the National Colorectal Cancer Roundtable, and is now the Co-Chair of that organization’s Public Outreach Committee. In New York, he is the co-chairman of the Citywide Colorectal Cancer Control Coalition (C5), having previously been co-Chairman of the Quality Subcommittee. His interests in endoscopy include new technology, reprocessing and infection control in endoscopy, training, quality in endoscopy, sedation, patient preparation, GERD, colon cancer screening and prevention, and capsule endoscopy.
Gil I. Ascunce, MD
Dr. Gil I. Ascunce is an independent gastroenterologist who is board certified in Gastroenterology and Internal Medicine. He attends to patients primarily in his office in Midtown Manhattan, and he also works at a nonprofit Community Health Center in the Lower East Side of Manhattan. Dr. Ascunce began his career as an Advanced Interventional Endoscopist but found his vocation in community practice and patient education. He transitioned his practice to provide medical care and education to his patients as a solo practitioner attending to all needs in Gastroenterology, Hepatology and Internal Medicine.
Dr. Ascunce graduated with honors from the Georgetown University School of Medicine and completed his Internal Medicine residency at the New York Presbyterian Hospital- Weill Cornell Medical Center. He then left New York to complete his fellowship in Gastroenterology at the University of Miami, in Florida. After completing the traditional fellowship, he returned to New York and completed an Advanced Interventional Endoscopy fellowship.
Dr. Ascunce is the chairman of the Private Practice Committee for NYSGE working to integrate our great academic institutions with our skilled and proficient gastroenterologists working independently in the New York area. He has experience working in an Ambulatory Surgery Center, Office Based Endoscopy practice, small group practice, solo practice, and in a community healthcare center.
Dr. Ascunce was born to Cuban and Spanish immigrant parents and is fluent in Spanish. He is native to the Washington, DC area and was a decorated student athlete at Georgetown University, leading the Hoyas to their first Big East Championship. He continues to enjoy athletic competition, cooking, hiking, and live music.
Adam Goodman, MD
I am an adult academic gastroenterologist with a clinical interest in gastrointestinal malignancy and disease. My clinical focus is primarily in the realm of pancreas, biliary diseases, colon cancer, and utilization of Endoscopic Ultrasound, ERCP, new technology, and other advanced endoscopic techniques for diagnosis and treatment of these disorders. I am a locally and nationally recognized leader in the field of Advanced Therapeutic Endoscopy. Upon starting my clinical work at NYU Langone Hospital Brooklyn, I created a clinical program in Endoscopic Ultrasound and have made us the premier referral center for this procedure as well as Advanced Endoscopy in Brooklyn.
In addition to my clinical interests I have focused a great amount of my career on fellow education. I work with and teach fellows daily and have been an Associate Program Director at SUNY Downstate and NYU Grossman School if Medicine. I have been fortunate to be a part of the NYSGE for many years and am a past president as well. This has given me the opportunity to not only teach locally, but nationally as well.
Melissa Latorre, MD
Dr. Melissa Latorre is the Section Chief of Gastroenterology and Hepatology at NYU Langone Health’s Manhattan Campus. She is a GI hospitalist, and her research focuses on improving the quality and efficiency of inpatient GI care. She is passionate about incorporating novel technology into the diagnosis and treatment of gastrointestinal bleeding. She serves as a member of the NYSGE Governing Council.
Shireen Pais, MD
Dr. Shireen Pais graduated from St John’s Medical College in Bangalore, India. She completed her internal medicine training at St Luke-Roosevelt Hospital/Columbia University in New York City. She went on to do her Fellowship in Gastroenterology and Hepatology at Los Angeles County- University of Southern California and continued an additional fellowship in Advanced Endoscopy at Indiana University, Indianapolis. Dr. Pais also served as junior faculty during her year at Indiana at the University Hospital and the Roudebush VA. On completion of her training, she served as Assistant Professor and then Associate Professor/Director of Endoscopic Ultrasound at New York Medical College, Westchester Medical Center from 2006 till 2017. In 2017, she moved to NYP-Hudson Valley to start a therapeutic gastroenterology service, and returned to WMC as Director of therapeutic endoscopy in 2020 and then Director of Endoscopy in 2021. She serves in many professional organizations in multiple roles and is active in academic medicine at numerous national and international level